1-4 of 4
prostate cancer, hormone-refractory
Close
Sort by
Journal Articles

Clinical Evidence Against the Continuum of Low-Primed Uncommitted Hematopoietic and Progenitor Cells (CLOUD-HSPC) Concept for Hematopoiesis

Ramon Mohanlal, PhD MD, Douglas W. Blayney, MD, Lan Huang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4860.
https://doi.org/10.1182/blood-2019-128563
Published: 2019
Journal Articles

Clinical Evidence of Granulocyte-Monocyte Progenitor (GMP) Stem Cell Involvement in Plinabulin's Mechanism of Action (MoA) for the Prevention of Docetaxel (Doc) Chemotherapy (Chemo)-Induced Neutropenia (CIN)

Douglas W. Blayney, MD, Lan Huang, PhD, Ramon Mohanlal, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4861.
https://doi.org/10.1182/blood-2019-127227
Published: 2019
Journal Articles

Microparticle-Associated Tissue Factor: A Molecular Link Between Coagulation Activation, Inflammation and Disease Progression in Early-Stage Prostate Cancer?

Katja Haubold, Michael Rink, Brigitte Spath, Ali Amirkhosravi, John L. Francis, Barbara Eifrig, Carsten Bokemeyer, MD, Florian Langer
Journal: Blood
Blood (2008) 112 (11): 3813.
https://doi.org/10.1182/blood.V112.11.3813.3813
Published: 2008
Journal Articles

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Pamela A. Davol, MEd, Jonathan M. Gall, BS, Ryan C. Grabert, BS, Wendy B. Young, RN, OCN, Francis J. Cummings, MD, Ritesh Rathore, MD, Gerald A. Colvin, DO, Gerald J. Elfenbein, MD, Lawrence G. Lum, MD, DSc
Journal: Blood
Blood (2004) 104 (11): 1349.
https://doi.org/10.1182/blood.V104.11.1349.1349
Published: 2004